COMPLEX GENERICS: OPPORTUNITIES & CHALLENGES
Journal Title: International Journal of Drug Regulatory Affairs - Year 2016, Vol 4, Issue 3
Abstract
Now a day, big pharmaceutical companies with sustainable revenues are more interested in complex products to minimize competitions. In line with the originator companies, many generic companies are also focusing on complex products, either a specialized dosage form of already approved product or generic version of approved specialized products i.e. complex generics. Inherent ‘complexity’ involved in such specialized products insulates fierce competition and are considered as potential opportunities with high revenues. U.S FDA approved specialized products with proprietary technologies, such as nanoparticles, microspheres or liposomes are most promising dosage forms. These dosage forms are proven to be safer, while providing better efficacy as compared to historically approved simpler dosage forms, by ensuring targeted delivery of drug towards the infected cells. In the era of recent scientific advances, many generic companies are investing in abundance for the development of complex generics in the segment of targeted delivery systems like liposomes, therapeutic nanoparticles for treatment of various diseases such as cancers, inflammatory disorders, infectious and cardiovascular diseases. Despite potential opportunities reside in developing complex generics in terms of safety, efficacy and high revenue, no authoritative article has enlightened the challenges relating to regulatory, scientific, clinical, intellectual property (IP) and commercialization of complex generics. The present article makes an attempt to address the challenges involved in a regulatory approval of such complex generics involving potential opportunity with low competition.
Authors and Affiliations
Vure Prasad, Kale Pooja
Keywords
Related Articles
- EP ID EP336989
- DOI 10.22270/ijdra.v4i3.184
- Views 120
- Downloads 0
REGULATIONS OF REGISTRATION AND IMPORT OF MEDICAL DEVICE IN INDIA
India is a huge market for medical devices and is increasing constantly for the last few years. The registration certificate and import license is mandatory for a manufacturer of India who wishes to import any medical de...
A STUDY ON HEAMPHILUS INFLUANZAE TYPE B DISEASE CAUSING ANTIGENS: AN APPROACH OF EPITOPE PREDICTION, ANTIGENICITY AND IMMUNOGENICITY PREDICTION
Vaccines work by mimicking disease agents and stimulating the immune system which in turn builds a defence mechanism against the disease causing agents. Some of the vaccines contain a part of the disease causing agents w...
METHOD DEVELOPMENT AND VALIDATION OF STABILITY INDICATING UPLC ASSAY METHOD FOR NIFEDIPINE
A simple and rapid stability indicating, ultra performance liquid chromatographic (UPLC) method was developed and validated for the determination of Nifedipine. The quantitative determination of Nifedipine drug was perfo...
FORMULATION AND EVALUATION OF NANOSUSPENSION OF ROSUVASTATIN CALCIUM
Poor water solubility and slow dissolution rate are issues for majority of upcoming and existing biologically active compounds. The aim of present work was to increase the dissolution rate of Rosuvastatin Calcium, a poor...
Pre-filled syringes in developed and developing region: An insight into Regulatory considerations
A Pre-filled syringe is a disposable syringe that is supplied already loaded with the substance to be injected. It is a unit dose of parenteral medication to which a needle has been fixed by a producer. They are small wh...